President and CEO Doug Love outlined a series of anticipated clinical and regulatory milestones during the 25th Annual ...

Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the contribution of the lectin pathway remains unclear. Lectin pathway-dependent ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

ARCHER II Topline Pivotal Phase 3 Data in Geographic Atrophy (GA) Expected Q4 2026; Vonaprument has Potential to Be the First Vision-Preserving ...

Immunoglobulin A (IgA) nephropathy results from the accumulation of IgA-containing immune complexes (IgA-ICs) and aberrant IgA antibodies in the glomerular mesangium. Now, researchers have found that ...

Investigational treatment improves outcomes without complete complement blockade ...

A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted ...

Discover large garden ideas to give your outdoor space more beauty and functionality. Think: pathways, trellises, raised beds ...

D-Wave Quantum stock gains attention amid institutional activity and quantum computing developments. Explore key drivers ...

At UC, 70% of undergrads participate in research, creative projects or service learning. Three new programs bridge classroom ...

Last October, commuters travelling along ­Craigflower Road might have noticed the­ ­sudden disappearance of a familiar ...

Detailed price information for Intl Business Machines (IBM-N) from The Globe and Mail including charting and trades.